Non-Interventional Trial About Treatment of Hemorrhages in Thyroid Surgery With TachoSil (TC-031-DE).

Trial Profile

Non-Interventional Trial About Treatment of Hemorrhages in Thyroid Surgery With TachoSil (TC-031-DE).

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2014

At a glance

  • Drugs Fibrinogen/thrombin (Primary)
  • Indications Haemorrhage
  • Focus Therapeutic Use
  • Sponsors Takeda Pharmaceuticals International GmbH
  • Most Recent Events

    • 07 May 2012 Company added as trial association as reported by ClinicalTrials.gov.
    • 16 Apr 2010 Planned end date changed from 1 Sep 2008 to 1 Jan 2009 as reported by ClinicalTrials.gov.
    • 07 Apr 2010 Actual patient number (482) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top